Moleculin Biotech, Inc. - Common Stock (MBRX)

Moleculin Biotech said on Wednesday that it is on track to treat the 45th patient with Annamycin as part of its Miracle study.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Moleculin Biotech will implement a 1-for-25 reverse stock split of its common stock, effective December 1.

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.